We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+22.98%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.69B
AUM Growth
+$481M
Cap. Flow
+$129M
Cap. Flow %
4.79%
Top 10 Hldgs %
44.27%
Holding
113
New
25
Increased
16
Reduced
30
Closed
12

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$32.8M
2
AAPL icon
Apple
AAPL
+$32.1M
3
AVBP icon
ArriVent BioPharma
AVBP
+$31.5M
4
ARGX icon
argenx
ARGX
+$26.4M
5
CRH icon
CRH
CRH
+$25.7M

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$55.4M
2
RPRX icon
Royalty Pharma
RPRX
+$48.3M
3
LVS icon
Las Vegas Sands
LVS
+$36.3M
4
MSFT icon
Microsoft
MSFT
+$33.4M
5
TERN
Terns Pharmaceuticals
TERN
+$29.2M

Sector Composition

Rank Sector Weight
1 Healthcare 57.97%
2 Technology 7.85%
3 Communication Services 7.05%
4 Consumer Discretionary 4.46%
5 Financials 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRL icon
101
Charles River Laboratories
CRL
$12.8B
$274K 0.01%
1,010
– –
AGIO icon
102
Agios Pharmaceuticals
AGIO
$1.93B
– –
-399,451
Closed -$8.9M
ANAB icon
103
AnaptysBio
ANAB
$1.68B
– –
-354,872
Closed -$7.6M
AZN icon
104
AstraZeneca
AZN
$250B
– –
-35,245
Closed -$4.75M
IDXX icon
105
Idexx Laboratories
IDXX
$46.2B
– –
-920
Closed -$511K
INCY icon
106
Incyte
INCY
$24.4B
– –
-37,600
Closed -$2.36M
KWEB icon
107
CALL
KraneShares CSI China Internet ETF
KWEB
$5.67B
– –
-900,000
Closed -$24.3M
LVS icon
108
Las Vegas Sands
LVS
$29.6B
– –
-738,163
Closed -$36.3M
MRK icon
109
Merck
MRK
$318B
– –
-15,500
Closed -$1.69M
PFE icon
110
Pfizer
PFE
$153B
– –
-50,300
Closed -$1.45M
SANA icon
111
Sana Biotechnology
SANA
$980M
– –
-1,606,056
Closed -$6.55M
TECH icon
112
Bio-Techne
TECH
$11.3B
– –
-2,600
Closed -$201K
UTHR icon
113
United Therapeutics
UTHR
$23.1B
– –
-1,360
Closed -$299K
1 2 3 4
5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Suvretta Capital Management held 113 positions worth $2.69B, up 22% from $2.21B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Suvretta Capital Management deployed $129M of net new capital in Q1 2024, opening 25 new positions and adding to 16 existing holdings. Its largest new stake was Coca-Cola: 546,500 shares worth $33.4M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 68% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Arcellx, an estimated $55.4M trimmed.

  • Suvretta Capital Management's largest Q1 2024 buy was Coca-Cola: 546,500 shares worth $33.4M.
  • Suvretta Capital Management added most to argenx in Q1 2024, an estimated $26.4M increase.
  • Suvretta Capital Management's biggest Q1 2024 reduction was Arcellx, cutting an estimated $55.4M.
  • Suvretta Capital Management fully exited Las Vegas Sands in Q1 2024, selling an estimated $36.3M.
  • Suvretta Capital Management's ten largest holdings make up 44% of its $2.69B portfolio in Q1 2024.
  • Suvretta Capital Management opened 25 new positions and closed 12 in Q1 2024.
  • Suvretta Capital Management's portfolio value rose 22% quarter-over-quarter to $2.69B.

Based on Suvretta Capital Management's 13F filing for Q1 2024, filed 15 May 2024.